An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas

An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas

<p>Abstract</p> <p>Background</p> <p>In ovarian cancer, the reported rate of EGFR expression varies between 4-70% depending on assessment method and data on patient outcome are conflicting. Methods: In this study we investigated EGFR expression and its prognostic value...

Full description

Bibliographic Details
Main Authors: Braicu Elena I, Sehouli Jalid, Buckendahl Ann-Christin, Darb-Esfahani Silvia, Weichert Wilko, Schwabe Michael, Noske Aurelia, Budczies Jan, Dietel Manfred, Denkert Carsten
Format: Article
Language:English
Published: BMC 2011-07-01
Series:BMC Cancer
Subjects:
EGFR
CRM1
COX-2
ovarian cancer
prognosis
Online Access:http://www.biomedcentral.com/1471-2407/11/294

Internet

http://www.biomedcentral.com/1471-2407/11/294

Similar Items